Baseline risk factors for QT interval prolongation in patients prescribed IV haloperidol

A. J. Muzyk, A. Rayfield, J. Y. Revollo, H. Heinz, J. P. Gagliardi

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalDrug Safety
DOIs
StatePublished - 1800

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this